Vladimir Maximilianovich Tolmachev - Genetic Mutations

Author Information

Vladimir Maximilianovich Tolmachev is affiliated with the Department of Immunology, Genetics and Pathology at Uppsala University in Uppsala, Sweden. His research primarily focuses on the application of radionuclide diagnostics and targeted nuclear medicine in oncology, particularly in the diagnosis and treatment of breast and prostate cancers.

Research Contributions

Vladimir M. Tolmachev has made significant contributions to the field of nuclear medicine and oncology. In 2022 alone, he has published several papers on the use of technetium-99m labeled recombinant target molecules for radionuclide diagnostics of HER2-positive breast cancer, exploring new developments in radionuclides for diagnostics and therapy of malignant tumors, and investigating the efficacy of novel targeted therapies in prostate cancer. His work is crucial in advancing the accuracy and efficacy of cancer diagnostics and treatment, particularly in the utilization of molecular imaging techniques like PET and SPECT.

Aliases

Vladimir Maximilianovich Tolmachev is also known by several aliases, including V. M. Tolmachev, Vladimir M. Tolmachev, V.m. Tolmachev, V. Tolmachev, V Tolmachev, and Vladimir Tolmachev.

Publication and Citation Metrics

Metric Value
Total Citation Count 11,450
h-index 55
Paper Count 479

Publications:

DOI: 10.1070/RCR5034

Year: 2022

Partnered Content Networks

Relevant Topics